|
Volumn 95, Issue 5, 2001, Pages 529-533
|
Effects of clomipramine on Trypanosoma cruzi infection in mice
a b a a a a |
Author keywords
Animal models; Chagas disease; Chemotherapy; Clomipramine; Electrocardiography; Heart; Histology; Mice; Trypanosoma cruzi
|
Indexed keywords
ANTITRYPANOSOMAL AGENT;
BETA ADRENERGIC RECEPTOR;
CALMODULIN;
CLOMIPRAMINE;
HEART RECEPTOR;
TRICYCLIC ANTIDEPRESSANT AGENT;
TRYPANOTHIONE REDUCTASE;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
CARDIOMYOPATHY;
CHAGAS DISEASE;
CLINICAL PRACTICE;
CONTROLLED STUDY;
DISEASE COURSE;
DISEASE MODEL;
DOSE RESPONSE;
DRUG EFFECT;
DRUG TARGETING;
ELECTROCARDIOGRAPHY;
ENZYME INHIBITION;
EPIMASTIGOTE;
HEART DISEASE;
HISTOPATHOLOGY;
IN VITRO STUDY;
MORTALITY;
MOUSE;
NONHUMAN;
RECEPTOR AFFINITY;
RECEPTOR DENSITY;
REPRODUCIBILITY;
SOUTH AND CENTRAL AMERICA;
TRYPANOSOMA CRUZI;
TRYPANOSOMIASIS;
TRYPOMASTIGOTE;
ANIMALS;
ANTIDEPRESSIVE AGENTS, TRICYCLIC;
CHAGAS CARDIOMYOPATHY;
CLOMIPRAMINE;
DRUG EVALUATION, PRECLINICAL;
ELECTROCARDIOGRAPHY;
MICE;
RECEPTORS, ADRENERGIC, BETA;
SURVIVAL ANALYSIS;
TRYPANOSOMA CRUZI;
ANIMALIA;
PROTOZOA;
TRYPANOSOMA;
TRYPANOSOMA CRUZI;
|
EID: 0035467566
PISSN: 00359203
EISSN: None
Source Type: Journal
DOI: 10.1016/S0035-9203(01)90029-X Document Type: Article |
Times cited : (21)
|
References (35)
|